Problem

Our client was interested in optimizing their pricing strategy and inform their 5-year forecast for a significant respiratory launch.  They needed to consider the implications of changes in stakeholders’ expectations in an increasingly competitive and changing environment

Solution

  • Structured 2-phase project in close collaboration with client:
  • Phase 1: Explored potential strategies through primary research with key stakeholders (qual/quant studies)
    • Linked Choice methodology assessed the impact of pricing dynamics by integrating interdependencies of all involved stakeholders (e.g., physicians, patients, and payers)
    • MaxDiff exercise assessed the most important contracting elements for payers
  • Phase 2: Finalized lead strategy through primary research and revenue optimization model

Outcome

  • Evaluated pricing decisions in terms of the final impact on the products’ patient share using a price/volume optimization
  • Provided physician-, patient- and payer- validated price sensitivities as well as further understanding of the differences in the level of influence that these stakeholders have on product prescribing